Group items tagged

The National Institute for Health and Care Excellence (NICE) today issued a draft guidance recommending dapagliflozin, sold under the brand name Forxiga among others, as an option for treating certain adults with chronic kidney disease (CKD). Dapagliflozin belongs to a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors. It is the first SGLT2 inhibitor to be recommended through NICE's technology appraisal process for CKD. Adding dapagliflozin to current standard care has been shown to significantly reduce the risk of having declining kidney function, end-stage kidney disease, or dying from causes related to the kidneys or cardiovascular system. "Dapagliflozin is a promising treatment for certain people with chronic kidney disease and it has the potential to increase the length of time before the disease gets worse," Meindert Boysen, deputy chief executive and director of the NICE Centre for Health Technology Evaluation, said.

Renew Hope!

Karma Ayurveda is one of the leading manufacturer and supplier of the Ayurvedic medicine and also find the best kidney treatment by our expert

It is a well known fact that suffering from kidney disease can be quite a difficult ordeal, something that is best avoided. The detection of the disease possibly could be tough at times since the symptoms sometimes might not appear till the kidney is said to have lost about 60% of the functionality.